Hematological malignancies: Incidence in Basse-Normandie, France, for 1997-2004

Revue d'Epidemiologie et de Sante Publique

Volumn 57, Issue 3, 2009, Pages

  Troussard, X ^a,b,c   Duchenet, V ^a   Cornet, E ^b   Mouchel, D ^a   Malet, M ^b   Collignon, A ^a  

^a Registre Régional des Hémopathies Malignes de Basse Normandie RRHMBN   (France)

^b CHU CÔTE DE NACRE   (France)

^c UNIVERSITÉ DE CAEN   (France)

Author keywords

Hematological malignancies; Incidence

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER INCIDENCE; CANCER REGISTRY; CHILD; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL PROTOCOL; FEMALE; FRANCE; HEMATOLOGIC MALIGNANCY; HODGKIN DISEASE; HUMAN; INFANT; LYMPHATIC LEUKEMIA; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; MYELOPROLIFERATIVE DISORDER; NONHODGKIN LYMPHOMA; PATIENT CARE; WALDENSTROEM MACROGLOBULINEMIA;

EID: 68649120659     PISSN: 03987620     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.respe.2009.02.207     Document Type: Article

References (28)

1. In: Fritz A., Percy C., Jack A., et al. (Eds). International Classification of Diseases for Oncology. 3rd ed. (2000), World Health Organization, Geneva, Switzerland
2. Clarke C.A., Undurraga D.M., Harasty P.J., Glaser S.L., Morton L.M., and Holly E.A. Changes in cancer registry coding for lymphoma subtypes: reliability over time and relevance for surveillance and study. Cancer Epidemiol Biomarkers Prev 15 (2006) 630-638
3. Pulte D., Gondos A., and Brenner H. Ongoing improvement in outcomes for patients diagnosed as having non-Hodgkin lymphoma from the 1990s to the early 21st century. Arch Intern Med 168 (2008) 469-476
4. Bennett J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D.A., Gralnick H.R., et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 51 (1982) 189-199
5. Morton L.M., Wang S.S., Devesa S.S., Hartge P., Weisenburger D.D., and Linet M.S. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood 107 (2006) 265-276
6. Rollison D.E., Howlader N., Smith M.T., Strom S.S., Merritt W.D., Ries L.A., et al. Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs. Blood 112 (2008) 45-52
7. Belot A., Grosclaude P., Bossard N., Jougla E., Benhamou E., Delafosse P., et al. Cancer incidence and mortality in France over the period 1980-2005. Rev Epidemiol Sante Publique 56 (2008) 159-175
8. Parkin D.M., Whelan S.L., Ferlay J., Teppo L., and Thomas D.B. Cancer incidence in five continents VIII (2002), IARC, Paris
9. Bouyer J., Hémon D., Cordier S., Derriennic F., Stücker I., Stengel B., et al. Épidémiologie - principes et méthodes quantitatives (1993), Éditions Inserm, Paris
10. Kamangar F., Dores G.M., and Anderson W.F. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24 (2006) 2137-2150
11. Brenner H., Gondos A., and Pulte D. Trends in long-term survival of patients with chronic lymphocytic leukemia from the 1980s to the early 21st century. Blood 111 (2008) 4916-4921
12. Phekoo K.J., Jack R.H., Davies E., Møller H., and Schey S.A. South Thames Haematology Specialist Committee. The incidence and survival of Waldenström's macroglobulinaemia in South East England. Leuk Res 32 (2008) 55-59
13. Linet M.S., Schubauer-Berigan M.K., Weisenburger D.D., Richardson D.B., Landgren O., Blair A., et al. Chronic lymphocytic leukaemia: an overview of aetiology in light of recent developments in classification and pathogenesis. Br J Haematol 139 (2007) 672-686
14. McMaster M.L., and Caporaso N. Waldenström macroglobulinaemia and IgM monoclonal gammopathy of undetermined significance: emerging understanding of a potential precursor condition. Br J Haematol 139 (2007) 663-671
15. Kyle R.A., and Rajkumar S.V. Epidemiology of the plasma-cell disorders. Best Pract Res Clin Haematol 20 (2007) 637-664
16. Craig C.M., and Schiller G.J. Acute myeloid leukemia in the elderly: conventional and novel treatment approaches. Blood Rev 22 (2008) 221-234
17. Cancers-environnement. Éditions Inserm, Collection Expertise collective 2008;907 p,ISBN: 978-2-85598-863-3.
18. Pobel D., and Viel J.F. Case-control study of leukaemia among young people near La Hague nuclear reprocessing plant: the environmental hypothesis revisited. Br Med J 314 (1997) 101-106
19. Guizard A.V., Spira A., Troussard X., and Collignon A. Incidence des leucémies de 0 à 24 ans dans le Nord-Cotentin. Rev Epidemiol Sante Publique 45 (1997) 530-535
20. Guizard A.V., Boutou O., Pottier D., et al. The incidence of Childhood leukaemia around the La Hague nuclear waste reprocessing plant (France): a survey for the years 1978-1998. J Epidemiol Community Health 55 (2001) 469-474
21. GRNC. Estimation des niveaux d'exposition aux rayonnements ionisants et des risques de leucémies associés de populations du Nord-Cotentin. Rapport de synthèse IPSN; 1999.
22. Laurier D., Rommens C., Drombry-Ringeard C., Merle-Szeremeta A., and Degrange J. Évaluation du risque de leucémie radio-induite à proximité d'installations nucléaires : l'étude radioécologique Nord-Cotentin. Rev Epidemiol Sante Publique 48 (2000) 2524-2536
23. Rommens C., Laurier D., and Sugier A. Methodology and results of the Nord-Cotentin radioecological study. J Radiol Prot 20 (2000) 361-380
24. o 2008-001.
25. e ed. (1997), Éditions Frison-Roche, Paris
26. Baldi I., and Lebailly P. Cancers et pesticides. Rev Prat 57 (2007) 40-44
27. Draper G., Vincent T., Kroll M.E., and Swanson J. Childhood cancer in relation to distance from high voltage power lines in England and Wales: a case-control study. Br Med J 330 (2005) 1290
28. Kinlen L.J., Dickson M., and Stiller C.A. Childhood leukaemia and non-Hodgkin's lymphoma near large rural construction sites, with comparison with Sellafield nuclear site. Br Med J 310 (1995) 763-768